By: Julia Bonavitacola
Poster data show the efficacy of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis.
Julia Bonavitacola is an associate editor at The American Journal of Managed Care® (AJMC®). She specializes in producing content related to various aspects of medicine and healthcare, including patient care, public health, and medical specialties such as oncology and dermatology. Her work has been featured in notable publications including Dermatology Times, Patient Care, and Managed Healthcare Executive.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
Julia's articles predominantly cite data and focus heavily on medical research, particularly in the areas of colorectal cancer, eye diseases, blood disorders, and lung cancer. Given this emphasis, she would likely be interested in receiving pitches from experts who can provide insights into recent studies or data related to these specific medical conditions.
She might also be open to discussions around new treatment methods or breakthroughs in these fields based on credible sources with a scientific background. Additionally, given her focus on citing data extensively, providing access to reputable and current research findings may increase the chances of successful outreach.
This information evolves through artificial intelligence and human feedback. Improve this profile .